EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The biased M3 mAChR ligand PD 102807 mediates qualitatively distinct signaling to regulate airway smooth muscle phenotype

Eric Tompkins, Bogdana Mimic, Raymond B Penn, Tonio Pera

Journal of Biological Chemistry · 2023

DOI: 10.1016/j.jbc.2023.105209 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023. Verfasst von Eric Tompkins und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Center for Translational Medicine, Jane and Leonard Korman Respiratory Institute, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Signal Transduction, Receptor, Muscarinic M3, Myocytes, Smooth Muscle, Muscle, Smooth. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Airway smooth muscle (ASM) cells attain a hypercontractile phenotype during obstructive airway diseases. We recently identified a biased M3 muscarinic acetylcholine receptor (mAChR) ligand, PD 102807, that induces GRK-/arrestin-dependent AMP-activated protein kinase (AMPK) activation to inhibit transforming growth factor-β-induced hypercontractile ASM phenotype. Conversely, the balanced mAChR agonist, methacholine (MCh), activates AMPK yet does not regulate ASM phenotype. In the current study, we demonstrate that PD 102807- and MCh-induced AMPK activation both depend on Ca2+/calmodulin-dependent kinase kinases (CaMKKs). However, MCh-induced AMPK activation is calcium-dependent and mediated by CaMKK1 and CaMKK2 isoforms. In contrast, PD 102807-induced signaling is calcium-independent and mediated by the atypical subtype protein kinase C-iota and the CaMKK1 (but not CaMKK2) isoform. Both MCh- and PD 102807-induced AMPK activation involve the AMPK α1 isoform. PD 102807-induced AMPK α1 (but not AMPK α2) isoform activation mediates inhibition of the mammalian target of rapamycin complex 1 (mTORC1) in ASM cells, as demonstrated by increased Raptor (regulatory-associated protein of mTOR) phosphorylation as well as inhibition of phospho-S6 protein and serum response element-luciferase activity. The mTORC1 inhibitor rapamycin and the AMPK activator metformin both mimic the ability of PD 102807 to attenuate transforming growth factor-β-induced α-smooth muscle actin expression (a marker of hypercontractile ASM). These data indicate that PD 102807 transduces a signaling pathway (AMPK-mediated mTORC1 inhibition) qualitatively distinct from canonical M3 mAChR signaling to prevent pathogenic remodeling of ASM, thus demonstrating PD 102807 is a biased M3 mAChR ligand with therapeutic potential for the management of obstructive airway disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Signal TransductionReceptor, Muscarinic M3Myocytes, Smooth MuscleMuscle, SmoothHumansCalcium-Calmodulin-Dependent Protein Kinase KinaseAMP-Activated Protein KinasesAnimalsMechanistic Target of Rapamycin Complex 1TOR Serine-Threonine KinasesMultiprotein ComplexesMethacholine ChloridePhenotypeLigandsCalciumEnzyme Activation

Stichwörter der Autor:innen

G protein-coupled receptorairwayairway smooth muscleasthmabiased receptor pharmacology

Substanzen

Calcium-Calmodulin-Dependent Protein Kinase KinaseAMP-Activated Protein KinasesReceptor, Muscarinic M3Mechanistic Target of Rapamycin Complex 1TOR Serine-Threonine KinasesMultiprotein ComplexesMethacholine ChlorideCAMKK2 protein, humanLigandsCalcium

Autor:innen und Institutionen

  • Department of Medicine, Center for Translational Medicine, Jane and Leonard Korman Respiratory Institute, Philadelphia, Pennsylvania, USA.
  • Department of Medicine, Center for Translational Medicine, Jane and Leonard Korman Respiratory Institute, Philadelphia, Pennsylvania, USA. Electronic address: tonio.pera@jefferson.edu.

Förderung

  • NHLBI NIH HHS
  • National Institutes of Health

Zitieren

APA

Tompkins, E., Mimic, B., Penn, R. B., & Pera, T. (2023). The biased M3 mAChR ligand PD 102807 mediates qualitatively distinct signaling to regulate airway smooth muscle phenotype. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.105209

Vancouver

Tompkins E, Mimic B, Penn RB, Pera T. The biased M3 mAChR ligand PD 102807 mediates qualitatively distinct signaling to regulate airway smooth muscle phenotype. Journal of Biological Chemistry. 2023. doi:10.1016/j.jbc.2023.105209

BibTeX
@article{Tompkins2023,
  author = {Tompkins, Eric and Mimic, Bogdana and Penn, Raymond B and Pera, Tonio},
  title = {The biased M3 mAChR ligand PD 102807 mediates qualitatively distinct signaling to regulate airway smooth muscle phenotype},
  journal = {Journal of Biological Chemistry},
  year = {2023},
  doi = {10.1016/j.jbc.2023.105209}
}
Kostenlos starten →